Skip to main content

Articles

Page 4 of 16

  1. Chinese health system remains the crucial one for understanding the wider healthcare landscape across the Global South and in particular the leading Emerging Markets. Purpose of our observation was to understa...

    Authors: Mihajlo Jakovljevic, Hanyu Chang, Jay Pan, Chao Guo, Jin Hui, Hao Hu, Danko Grujic, Zhong Li and Lizheng Shi
    Citation: Cost Effectiveness and Resource Allocation 2023 21:59
  2. Breast cancer is one of the main causes of death from cancer around the world, imposing a significant economic burden on the families and healthcare system. The present study aimed at determining the economic ...

    Authors: Faride Sadat Jalali, Khosro Keshavarz, Mozhgan Seif, Majid Akrami, Abdosaleh Jafari and Ramin Ravangard
    Citation: Cost Effectiveness and Resource Allocation 2023 21:58

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2023 21:71

  3. Policymakers in sub-Saharan Africa (SSA) face challenging decisions regarding the allocation of health resources. Economic evaluations can help decision makers to determine which health interventions should be...

    Authors: Samantha A Hollingworth, Glory-Anne Leaupepe, Justice Nonvignon, Ama Pokuaa Fenny, Emmanuel A. Odame and Francis Ruiz
    Citation: Cost Effectiveness and Resource Allocation 2023 21:57
  4. Authors: Federico Augustovski, Ariel Bardach, Adrián Santoro, Federico Rodriguez-Cairoli, Alejandro López-Osornio, Fernando Argento, Maissa Havela, Alejandro Blumenfeld, Jamile Ballivian, Germán Solioz, Analía Capula, Analía López, Cintia Cejas, William Savedoff, Alfredo Palacios, Adolfo Rubinstein…
    Citation: Cost Effectiveness and Resource Allocation 2023 21:56

    The original article was published in Cost Effectiveness and Resource Allocation 2023 21:21

  5. U.S. cost-effectiveness recommendations suggest that analyses should include all costs and effects relevant to the decision problem [1]. However, in many diseases, including spinal muscular atrophy (SMA), few stu...

    Authors: Abigail G. Riley, Christina M. Mulé, Debra Lerner, Lisa Belter, Colleen McCarthy O’Toole, Stacey Kowal, David Fox, Sheila Shapouri, Tamara Vesel and Tara A. Lavelle
    Citation: Cost Effectiveness and Resource Allocation 2023 21:55
  6. Iran government implemented the targeted subsidy plan in December 2010 to reduce energy consumption and inequality. In addition, the Health Transformation Plan was implemented by the Ministry of Health to redu...

    Authors: Yousef Mohammadzadeh, Aysan Sheikhmali, Jafar Yahyavi Dizaj, Ali Mohammad Mosadeghrad, Hasan Yusefzadeh and Arash Refah Kahriz
    Citation: Cost Effectiveness and Resource Allocation 2023 21:54
  7. In Morocco, hospitals do not have cost accounting systems that allow them to produce reliable budget forecasts to know and justify the costs of their operations. Moroccan hospitals are thus among the public or...

    Authors: A. Benabdallah and T. Jellouli
    Citation: Cost Effectiveness and Resource Allocation 2023 21:53
  8. The morbidity and mortality of adult diseases caused by S. pneumoniae increase with age and presence of underlying chronic diseases. Currently, two vaccine technologies against S. pneumoniae are used: the 23-vale...

    Authors: Mikkelsen Malene B, Husby Oyvind, Molden Tor, Mwaura David N, Olsen Jens, Kristensen Nanna V and Vietri Jeffrey
    Citation: Cost Effectiveness and Resource Allocation 2023 21:52
  9. Alzheimer's Disease (AD), the most common type of dementia, is a chronic, progressive, and neurodegenerative brain discomfort that causes the be damage to brain cells. Although there is no definitive treatment...

    Authors: Vahit Yigit, Selin Kalender and Iskender Cetinturk
    Citation: Cost Effectiveness and Resource Allocation 2023 21:51
  10. The Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE) Study cluster-randomized 86 primary care practices in 10 healthcare systems to a patient-centered multifactorial fall injury preventi...

    Authors: David A. Ganz, Thomas M. Gill, David B. Reuben, Shalender Bhasin, Nancy K. Latham, Peter Peduzzi and Erich J. Greene
    Citation: Cost Effectiveness and Resource Allocation 2023 21:49
  11. INES (INteractive model for Extrapolation of Survival and cost) provides an open-access tool powered by R that implements three-state partitioned survival models (PSM). This article describes the properties of...

    Authors: Vicente Gimeno-Ballester, Daniel Perez-Troncoso, Antonio Olry-Labry and David Epstein
    Citation: Cost Effectiveness and Resource Allocation 2023 21:48
  12. Breast cancer-related lymphedema (BCRL) imposes a significant economic burden on patients, providers, and society. There is no curative therapy for BCRL, but management through self-care can reduce symptoms an...

    Authors: Pinar Karaca-Mandic, Craig A. Solid, Jane M. Armer, Roman Skoracki, Elizabeth Campione and Stanley G. Rockson
    Citation: Cost Effectiveness and Resource Allocation 2023 21:47
  13. Stereotactic body radiotherapy (SBRT) is a novel radio-therapeutic technique that has recently emerged as standard-of-care treatment for medically inoperable, early-stage non-small cell lung cancer (NSCLC). In...

    Authors: Hui Sun, Huishan Wang, Yan Wei, Haiyin Wang, Chunlin Jin and Yingyao Chen
    Citation: Cost Effectiveness and Resource Allocation 2023 21:46
  14. Ceftazidime avibactam (CA) is an effective treatment against carbapenem-resistant Enterobacteriaceae (CRE), but its cost-effectiveness is unclear. This study was performed to evaluate the cost-effectiveness of...

    Authors: Zahra Goudarzi, Fattaneh Danayi, Khosro Keshavarz and Ahmad Gholami
    Citation: Cost Effectiveness and Resource Allocation 2023 21:45
  15. The Central Government of India introduced the National Health Mission (NHM) in 2005 to improve health outcomes by enhancing publicly financed (government) health expenditure and health infrastructure at the s...

    Authors: Ranjan Kumar Mohanty and Deepak Kumar Behera
    Citation: Cost Effectiveness and Resource Allocation 2023 21:44
  16. A health-economic evaluation related to COVID-19 is urgently needed to allocate healthcare resources efficiently; however, relevant medical cost data in Japan concerning COVID-19 are scarce.

    Authors: Shunsuke Uno, Rei Goto, Kimiko Honda, Machiko Tokuda, Hirofumi Kamata, Shotaro Chubachi, Ryo Yamamoto, Yukio Sato, Koichiro Homma, Sho Uchida, Ho Namkoong, Yoshifumi Uwamino, Junichi Sasaki, Koichi Fukunaga and Naoki Hasegawa
    Citation: Cost Effectiveness and Resource Allocation 2023 21:43
  17. In Colombia, the best strategy to establish indication for adjuvant chemotherapy in early breast cancer (EBC) remains unknown. This study aimed to identify the cost-utility of Oncotype DXâ„¢ (ODX) or Mammaprintâ„¢...

    Authors: Leonardo Rojas, María X. Rojas-Reyes, Diego Rosselli, Juan Guillermo Ariza, Alejandro Ruiz-Patiño and Andrés F. Cardona
    Citation: Cost Effectiveness and Resource Allocation 2023 21:42
  18. Diabetes is one of the most prevalent chronic diseases with subsequent complications. The positive effects of diabetes pay-for-performance (P4P) programs on treatment outcomes have been reported. The program p...

    Authors: Ming-Chan Sung, Kuo-Piao Chung and Shou-Hsia Cheng
    Citation: Cost Effectiveness and Resource Allocation 2023 21:41
  19. To estimate and compare the cost-effectiveness of COVID-19 critical care intervention approaches: noninvasive (oxygen without intubation) and invasive (intubation) management in Ethiopia.

    Authors: Senait Alemayehu Beshah, Arega Zeru, Wogayehu Tadele, Atkure Defar, Theodros Getachew and Lelisa Fekadu Assebe
    Citation: Cost Effectiveness and Resource Allocation 2023 21:40
  20. Cardiovascular diseases, such as stroke and ischemic heart disease attributable to hypertension, are major causes of premature death in Japan and worldwide. Nevertheless, a low rate of blood pressure control a...

    Authors: Narimasa Kumagai, Shuzo Nishimura and Mihajlo Jakovljević
    Citation: Cost Effectiveness and Resource Allocation 2023 21:39
  21. The duration of treatment (DOT) of the initial intervention and subsequent treatment is the key to determining the accuracy of anticancer-drug budget impact analysis (BIA) calculations. However, existing studi...

    Authors: Yue Ma, Jiting Zhou, Yuxin Ye, Aixia Ma and Hongchao Li
    Citation: Cost Effectiveness and Resource Allocation 2023 21:38
  22. The objective of this study was to estimate the willingness to pay (WTP) per quality-adjusted life year (QALY) among people with malignancies in China. The WTP for a QALY was estimated using a contingent valua...

    Authors: Li Huang, Xiaochen Peng, Lihua Sun and Dawei Zhang
    Citation: Cost Effectiveness and Resource Allocation 2023 21:37
  23. Chronic obstructive pulmonary disease (COPD) is a progressive debilitating condition with frequent exacerbations that have a high burden for patients and society. Digital tools may help to reduce the economic ...

    Authors: Timothy J. Inocencio, Kimberly L. Sterling, Sibel Sayiner, Michael E. Minshall, Leanne Kaye and Umur HatipoÄŸlu
    Citation: Cost Effectiveness and Resource Allocation 2023 21:36
  24. Approximately 30–70% of patients who have undergone allogeneic (allo) hematopoietic stem cell transplantation (HSCT) eventually experience chronic graft-versus-host disease (cGVHD). Patients who develop steroi...

    Authors: Jian Chun Matthew Ong, Hein Than, Sandeep Tripathi, Christina Gkitzia and Xiaojun Wang
    Citation: Cost Effectiveness and Resource Allocation 2023 21:34
  25. Most cervical cancer patients in developing countries seek care in health facilities with an advanced disease, often characterized by obstructive uropathy. This study aims to estimate the cost of an image-guid...

    Authors: Amani Thomas Mori and Cecilia J. Nyabakari
    Citation: Cost Effectiveness and Resource Allocation 2023 21:33
  26. By evaluating equity and effectiveness, this study provides evidence-based knowledge for scientific decision-making and the optimization of magnetic resonance imaging (MRI) configuration and utilization at the...

    Authors: Xiaoling Huang, Yan Wei, Hui Sun, Jiaqi Huang, Yingyao Chen and Jingliang Cheng
    Citation: Cost Effectiveness and Resource Allocation 2023 21:32
  27. Economic analyses of healthcare interventions are an important consideration in evidence-based policymaking. A key component of such analyses is the costs of interventions, for which most are familiar with usi...

    Authors: Hugo C. Turner, Frank G. Sandmann, Laura E. Downey, Stacey Orangi, Yot Teerawattananon, Anna Vassall and Mark Jit
    Citation: Cost Effectiveness and Resource Allocation 2023 21:31
  28. The FLURESP project is a public health research funded by the European Commission, with the objective to design a methodological framework to assess the cost-effectiveness of existing public health measures ag...

    Authors: Ariel Beresniak, Christian Napoli, John Oxford, Alejandra Daruich, Laurent Niddam, Gérard Duru, Alberto E. Tozzi, Marta Ciofi degli Atti, Danielle Dupont, Caterina Rizzo and Dominique Bremond-Gignac
    Citation: Cost Effectiveness and Resource Allocation 2023 21:30
  29. The aim of this study was to investigate the health and economic outcomes of a universal early intervention for parents and children, the Salut Programme, from birth to when the child completed five years of age.

    Authors: Filipa Sampaio, Jenny Häggström, Richard Ssegonja, Eva Eurenius, Anneli Ivarsson, Anni-Maria Pulkki-Brännström and Inna Feldman
    Citation: Cost Effectiveness and Resource Allocation 2023 21:29
  30. Thumb carpometacarpal (CMC) joint arthritis is one of the most prevalent arthritic conditions commonly treated with trapeziectomy alone or trapeziectomy with ligament reconstruction and tendon interposition (L...

    Authors: Alfred P. Yoon, David W. Hutton and Kevin C. Chung
    Citation: Cost Effectiveness and Resource Allocation 2023 21:28
  31. Different healthcare reforms could affect the productivity of hospitals. The aim of this study was to track hospital productivity before and after the recent Iranian healthcare reform in Khuzestan province, So...

    Authors: Sajad Vahedi, Mansour Zahiri, Narges Pirani and Amin Torabipour
    Citation: Cost Effectiveness and Resource Allocation 2023 21:26
  32. Understanding related risk factors of health-related quality of life (HRQoL) could avoid treatment failure and provide an insight of personalized treatment approach among people living with HIV/AIDS (PLWH). Th...

    Authors: Ming Guan and Hongyi Guan
    Citation: Cost Effectiveness and Resource Allocation 2023 21:25
  33. Authors: Mandy Maredza, Kamran Khan, Ioana R. Marian, Susan J. Dutton, Esther Williamson, Sarah E. Lamb and Stavros Petrou
    Citation: Cost Effectiveness and Resource Allocation 2023 21:24

    The original article was published in Cost Effectiveness and Resource Allocation 2023 21:14

  34. Increasing evidence has demonstrated the effectiveness and safety of vitamin D supplementation to prevent acute respiratory infections in children. More economic evaluations incorporating the new evidence and ...

    Authors: Jefferson Antonio Buendía and Diana Guerrero Patiño
    Citation: Cost Effectiveness and Resource Allocation 2023 21:23
  35. Informal care can reduce hospitalization frequency and time, elevate bed turnover, and increase the health systems' capacity. This type of care has shown meaningful value in managing many cases through the COV...

    Authors: Vajiheh Ramezani-Doroh, Faride Karimi, Maryam Rangchian and Yadolah Hamidi
    Citation: Cost Effectiveness and Resource Allocation 2023 21:22
  36. Our study analyzes the cost-effectiveness of the COVID-19 vaccination campaigns in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru.

    Authors: Federico Augustovski, Ariel Bardach, Adrián Santoro, Federico Rodriguez-Cairoli, Alejandro López-Osornio, Fernando Argento, Maissa Havela, Alejandro Blumenfeld, Jamile Ballivian, Germán Solioz, Analía Capula, Analía López, Cintia Cejas, William Savedoff, Alfredo Palacios, Adolfo Rubinstein…
    Citation: Cost Effectiveness and Resource Allocation 2023 21:21

    The Publisher Correction to this article has been published in Cost Effectiveness and Resource Allocation 2023 21:56

  37. Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide, especially in China. According to the 2021 Chinese Society of Clinical Oncology guidelines, sorafenib, lenvatinib,...

    Authors: Hongyu Gong, Siew Chin Ong, Fan Li, Zhiying Weng, Keying Zhao and Zhengyou Jiang
    Citation: Cost Effectiveness and Resource Allocation 2023 21:20
  38. Durvalumab plus gemcitabine and cisplatin has a significant clinical benefit for advanced biliary tract cancer (BTC). However, the high price of durvalumab warrants an exploration of the economics.

    Authors: Qiuling Zhao, Ruixiang Xie, Wanfu Zhong, Wenbin Liu, Ting Chen, Xiuliang Qiu and Lin Yang
    Citation: Cost Effectiveness and Resource Allocation 2023 21:19
  39. Mental illnesses account for a considerable proportion of the global burden of disease. Economic evaluation of public policies and interventions aimed at mental health is crucial to inform decisions and improv...

    Authors: Igor Larrañaga, Oliver Ibarrondo, Lorea Mar-Barrutia, Myriam Soto-Gordoa and Javier Mar
    Citation: Cost Effectiveness and Resource Allocation 2023 21:18
  40. Since Shiraz Transplant Center is one of the major transplant centers in Iran and the Middle East, this study was conducted to evaluate outcomes of the applied policies on COVID-19 detection and management.

    Authors: Mojtaba Shafiekhani, Tahmoores Niknam, Seyed Ahmad Tara, Parviz Mardani, Khatereh Mirzad Jahromi, Sedigheh Jafarian, Sara Arabsheybani, Halimeh Negahban, Majid Hamzehnejadi, Zahra Zare, Khadijeh Ghaedi Ghalini, Ali Ghasemnezhad, Mahmoud Akbari, Reza Shahriarirad and Seyed Ali MalekHosseini
    Citation: Cost Effectiveness and Resource Allocation 2023 21:17
  41. Cost-effectiveness analysis plays a key role in evaluating health systems and services. Coronary artery disease is one of the primary health concerns worldwide. This study sought to compare the cost-effectiven...

    Authors: NourolHoda Fakhrzad, Mohsen Barouni, Reza Goudarzi, Javad Kojuri, Yunes Jahani and Mohammad Tasavon Gholamhoseini
    Citation: Cost Effectiveness and Resource Allocation 2023 21:16
  42. Essential Emergency and Critical Care (EECC) is a novel approach to the care of critically ill patients, focusing on first-tier, effective, low-cost, life-saving care and designed to be feasible even in low-re...

    Authors: Lorna Guinness, Angela Kairu, August Kuwawenaruwa, Karima Khalid, Khamis Awadh, Vincent Were, Edwine Barasa, Hiral Shah, Peter Baker, Carl Otto Schell and Tim Baker
    Citation: Cost Effectiveness and Resource Allocation 2023 21:15
  43. Emerging evidence suggests that structured and progressive exercise underpinned by a cognitive behavioural approach can improve functional outcomes in patients with neurogenic claudication (NC). However, evide...

    Authors: Mandy Maredza, Kamran Khan, Ioana R. Marian, Susan J. Dutton, Esther Williamson, Sarah E. Lamb and Stavros Petrou
    Citation: Cost Effectiveness and Resource Allocation 2023 21:14

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2023 21:24

  44. Rehabilitation is an essential medical service for patients who have suffered acute stroke. Although the effectiveness of 7-days-per-week rehabilitation schedule has been studied in comparison with 5- or 6-day...

    Authors: Yasuhiro Morii, Kagari Abiko, Toshiya Osanai, Jiro Takami, Takumi Tanikawa, Kensuke Fujiwara, Kiyohiro Houkin and Katsuhiko Ogasawara
    Citation: Cost Effectiveness and Resource Allocation 2023 21:12
  45. The aims of this study was to appraise the health economic evidence for adjuvant chemotherapy (AC) strategies in stage II and III colon cancer (CC) and identify gaps in the available evidence that might inform...

    Authors: Yat Hang To, Peter Gibbs, Jeanne Tie, Maarten IJzerman and Koen Degeling
    Citation: Cost Effectiveness and Resource Allocation 2023 21:11
  46. Renal cell carcinoma (RCC) is the most common type of kidney cancer. VEGF inhibitors and mTORs are the most common therapeutic options among the different classes of available treatments. In this study, the ef...

    Authors: Zahra Goudarzi, Mehrdad Mostafavi, Mahmood Salesi, Mojtaba Jafari, Iman Mirian, Amir Hashemi Meshkini, Khosro Keshavarz and Younes Ghasemi
    Citation: Cost Effectiveness and Resource Allocation 2023 21:10

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 1.7
    5-year Journal Impact Factor: 2.1
    Source Normalized Impact per Paper (SNIP): 0.749
    SCImago Journal Rank (SJR): 0.610

    Speed 2024
    Submission to first editorial decision (median days): 10
    Submission to acceptance (median days): 168

    Usage 2024
    Downloads: 550,922
    Altmetric mentions: 312